Cumberland Pharma

CPIX

4.3500.00% ( 0.000 )

Closed: Oct 27, 09:20:00 (EDT)

Current ValuationThe current P/E ratio is -5.97, above the reasonable range, cheaper than 0% of the time in the past 1 years, and the industry ranks 177/256, the industry Median -1.06.

-5.97xP/E

Stock price$4.35Earnings per share$-0.73

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

0285684112

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x20x40x60x80x100x

P/E ratio
Name/Symbol
TAKUSTakeda Pharmaceutical Company	-61.78x	146.63%	$64.54B
BAYRYUSBayer	-24.75x	--	$49.87B
BAYZFUSBayer Aktiengesellschaft	-24.84x	--	$50.03B
VTRSUSViatris	-51.15x	107.68%	$21.01B
ELANUSElanco Animal Health	-57.64x	130.52%	$11.47B
VREOFUSVIREO GROWTH INC	-113.08x	--	$7.59B
AXSMUSAxsome Therap	-39.37x	20.27%	$7.55B
CURLFUSCuraleaf Holdings, Inc.	-117.70x	--	$6.12B
BLTEUSBelite Bio	-56.40x	29.87%	$5.77B
MANEUSVeraDermics	-55.04x	97.44%	$5.74B
DFTXUSDefinium Therapeutics	-13.55x	54.55%	$4.79B
EWTXUSEdgewise Therapeutics	-21.57x	207.38%	$4.25B
AMLXUSAmylyx Pharmaceuticals	-22.36x	1.76%	$3.40B
RGCUSRegencell Bioscience	-286.23x	--	$3.35B
TARSUSTarsus Pharmaceuticals	-66.12x	345.28%	$3.07B
ELVNUSEnliven Therapeutics	-28.70x	5.59%	$3.04B
MBXUSMBX Biosciences	-23.22x	31.12%	$2.42B
BHCUSBausch Health	-2.16x	569.84%	$2.37B
SUPNUSSupernus Pharma	-21.57x	66.18%	$2.37B
PHVSUSPharvaris BV	-11.18x	10.43%	$2.21B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.